October 2014 Webinar – Family Genetics

Family Genetics Learning about health, family history and what information to collect is important! Join us as we prepare for November as Health History Month. The holidays provide an excellent opportunity for families to share health history. Join us to learn about colorectal cancer and cancer diagnosis, and what this means for you and your family.…  Read More

Understanding the process of clinical trials

Have you encountered a crossroad when it comes to treatment? Are current therapy routes not working, or working as well as you and your doctors hoped? If you’ve encountered this deadlock, you may want to consider participating in a clinical trial. What are clinical trials? Clinical trials are designed to test new avenues in treatment, sometimes…  Read More

Medicare Now Covers Stool DNA Screening Test Cologuard

Last week, the Centers for Medicare & Medicaid Services (CMS) announced that Cologuard is now covered for Medicare patients based on a CMS National Coverage Decision. This is exciting news as most people who are already enrolled in Medicare will not face co-pays or co-insurance if they obtain a Cologuard kit. It is important to note…  Read More

FINANCIAL TOXICITY IS A SIDE EFFECT

THE COST OF CANCER TREATMENT Although the high cost of cancer treatment has been a growing issue in the United States for a number of years, it has recently been focused on in the mainstream media. On October 5, 2014 CBS News 60 Minutes aired an episode featuring correspondent Lesley Stahl interviewing several prominent cancer doctors…  Read More

September 2014 Webinar – Coping with Cancer

Coping after cancer – what does this mean and how can coping help you? Whether you’ve just been diagnosed with colorectal cancer or are managing side effects after treatment, you have been impacted greatly and life has likely changed. Coping strategies can help you regain a sense of control, and learn that there is always hope…  Read More

Ramucirumab Treatment

There’s news coming out of a recent clinical trial evaluating the chemotherapy drug ramucirumab (Cyramza™) and colorectal cancer patients’ response. Read more to learn about this update in treatment. Breaking research for mCRC patients Recently Eli Lilly and Company announced that the RAISE trial showed a statistically significant improvement for patients treated with ramucirumab (Cyramza™). This…  Read More